|

Cell-Free DNA Chromatin Immunoprecipitation (ChIP) for Diagnosing Cancer

RECRUITINGSponsored by University of Central Florida
Actively Recruiting
SponsorUniversity of Central Florida
Started2023-05-24
Est. completion2025-05
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT06148298

Summary

The goal of this research is to use chromatin immunoprecipitation, a method used to study protein-DNA interaction, as a tool to diagnose and prognose pancreatic ductal adenocarcinoma in human samples. This is a Non-Human Subject Research study. All participants are de-identified.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* 18 years old or older
* Pancreatic cancer patients

Exclusion Criteria:

* Children may not register
* Persons who are unable to consent may not register

Conditions2

CancerCancer of Pancreas

Locations1 site

University of Central Florida
Orlando, Florida, 32816

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.